Pages that link to "Item:Q2033441"

The following pages link to Mathematical modeling of an immune checkpoint inhibitor and its synergy with an immunostimulant (Q2033441):

Displaying 29 items.

• In silico synergism and antagonism of an anti-tumour system intervened by coupling immunotherapy and chemotherapy: a mathematical modelling approach (Q417370) (← links)
• Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer (Q827694) (← links)
• Developing a minimally structured mathematical model of cancer treatment with oncolytic viruses and dendritic cell injections (Q1728847) (← links)
• A mathematical model of the enhancement of tumor vaccine efficacy by immunotherapy (Q1758078) (← links)
• Dynamics of immune checkpoints, immune system, and BCG in the treatment of superficial bladder cancer (Q1784129) (← links)
• Use of quasi-normal form to examine stability of tumor-free equilibrium in a mathematical model of BCG treatment of bladder cancer (Q1942465) (← links)
• Computation of the conditions for anti-angiogenesis and gene therapy synergistic effects: sensitivity analysis and robustness of target solutions (Q2049195) (← links)
• Mathematical modeling for the combination treatment of IFN-\(\gamma\) and anti-PD-1 in cancer immunotherapy (Q2103601) (← links)
• A mathematical model for cancer treatment based on combination of anti-angiogenic and immune cell therapies (Q2104157) (← links)
• Cancer therapy with immune checkpoint inhibitor and CSF-1 blockade: a mathematical model (Q2109247) (← links)
• Dynamic analysis of a model on tumor-immune system with regulation of PD-1/PD-L1 and stimulation delay of tumor antigen (Q2156325) (← links)
• Modeling the effect of gut microbiome on therapeutic efficacy of immune checkpoint inhibitors against cancer (Q2164665) (← links)
• Mathematical modeling, analysis, and simulation of tumor dynamics with drug interventions (Q2283759) (← links)
• A mathematical model of tumor-immune interactions with an immune checkpoint inhibitor (Q2286039) (← links)
• Modelling of killer T-cell and cancer cell subpopulation dynamics under immuno- and chemotherapies (Q2294472) (← links)
• Mathematical modeling of cancer treatment with radiation and PD-L1 inhibitor (Q2303919) (← links)
• Response of patients with melanoma to immune checkpoint blockade -- insights gleaned from analysis of a new mathematical mechanistic model (Q2335370) (← links)
• Mathematical modelling of autoimmune myocarditis and the effects of immune checkpoint inhibitors (Q2670147) (← links)
• On modeling the synergy of cancer immunotherapy with radiotherapy (Q2684058) (← links)
• Stability and Hopf bifurcation of a tumor-immune system interaction model with an immune checkpoint inhibitor (Q2684070) (← links)
• A feedback control model of comprehensive therapy for treating immunogenic tumours (Q2806163) (← links)
• A Delayed Dynamical Model Describing the Effect of Tumor-Induced Vascular Endothelial Growth Factor on Angiogenesis: Backward Bifurcations and Global Dynamics (Q5094749) (← links)
• Combination therapy for cancer with IL-27 and anti-PD-1: A simplified mathematical model (Q5879157) (← links)
• Bifurcation Analysis in a Tumor-Immune System Interaction Model with Dendritic Cell Therapy and Immune Response Delay (Q6073296) (← links)
• Analysis of tumor-immune functional responses in a mathematical model of neoantigen cancer vaccines (Q6098904) (← links)
• Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma (Q6147712) (← links)
• Treatment of melanoma with dendritic cell vaccines and immune checkpoint inhibitors: a mathematical modeling study (Q6174314) (← links)
• Bifurcations of a cancer immunotherapy model explaining the transient delayed response and various other responses (Q6551766) (← links)
• Mathematical modeling and solution landscape reveal cancer progression dynamics in tumor ecological microenvironment (Q6669436) (← links)